Mn Services Vermogensbeheer B.V. Increases Stock Position in Solventum Corporation $SOLV

Key Points

• Mn Services Vermogensbeheer B.V. increased its stake in Solventum Corporation by 12.0%, owning a total of 54,932 shares valued at approximately $4.17 million following the purchase of an additional 5,900 shares.
• Several other institutions, including Independent Franchise Partners LLP and Assenagon Asset Management S.A., significantly expanded their holdings in Solventum, demonstrating increasing institutional interest in the company.
• Solventum recently reported an EPS of $1.69, surpassing the consensus estimate, with its quarterly revenue reaching $2.16 billion, along with setting FY 2025 guidance of 5.800-5.950 EPS.

Mn Services Vermogensbeheer B.V. boosted its holdings in shares of Solventum Corporation (NYSE:SOLV - Free Report) by 12.0% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 54,932 shares of the company's stock after acquiring an additional 5,900 shares during the quarter. Mn Services Vermogensbeheer B.V.'s holdings in Solventum were worth $4,166,000 at the end of the most recent quarter.

Other institutional investors have also recently added to or reduced their stakes in the company. Rossby Financial LCC bought a new stake in shares of Solventum in the 1st quarter valued at $25,000. Strengthening Families & Communities LLC boosted its stake in shares of Solventum by 376.8% in the 1st quarter. Strengthening Families & Communities LLC now owns 329 shares of the company's stock valued at $25,000 after purchasing an additional 260 shares during the last quarter. Hara Capital LLC bought a new stake in shares of Solventum in the 1st quarter valued at $38,000. Smartleaf Asset Management LLC boosted its stake in shares of Solventum by 193.4% in the 1st quarter. Smartleaf Asset Management LLC now owns 534 shares of the company's stock valued at $40,000 after purchasing an additional 352 shares during the last quarter. Finally, Costello Asset Management INC acquired a new position in shares of Solventum during the 1st quarter valued at $42,000.

Analysts Set New Price Targets

A number of research analysts recently issued reports on the stock. Jefferies Financial Group assumed coverage on shares of Solventum in a research report on Thursday, September 11th. They set a "hold" rating and a $80.00 target price on the stock. Zacks Research upgraded shares of Solventum from a "hold" rating to a "strong-buy" rating in a research report on Monday, September 15th. Wells Fargo & Company upped their price objective on shares of Solventum from $79.00 to $82.00 and gave the stock an "equal weight" rating in a report on Monday, September 15th. Wall Street Zen downgraded shares of Solventum from a "strong-buy" rating to a "buy" rating in a report on Tuesday, September 9th. Finally, Argus upgraded shares of Solventum from a "hold" rating to a "buy" rating and set a $90.00 price objective on the stock in a report on Tuesday, July 1st. One research analyst has rated the stock with a Strong Buy rating, four have issued a Buy rating, six have issued a Hold rating and one has given a Sell rating to the stock. According to MarketBeat, the company presently has a consensus rating of "Hold" and a consensus target price of $85.44.

Solventum Stock Performance

SOLV traded down $0.04 during trading on Tuesday, hitting $73.73. 133,110 shares of the company traded hands, compared to its average volume of 1,085,143. The firm has a market cap of $12.78 billion, a P/E ratio of 34.13, a price-to-earnings-growth ratio of 3.00 and a beta of 0.53. The stock's fifty day moving average is $72.97 and its 200 day moving average is $72.32. The company has a quick ratio of 0.86, a current ratio of 1.22 and a debt-to-equity ratio of 2.14. Solventum Corporation has a one year low of $60.70 and a one year high of $85.92.

Solventum (NYSE:SOLV - Get Free Report) last posted its quarterly earnings results on Thursday, August 7th. The company reported $1.69 earnings per share for the quarter, beating the consensus estimate of $1.45 by $0.24. The company had revenue of $2.16 billion during the quarter, compared to analyst estimates of $2.12 billion. Solventum had a net margin of 4.52% and a return on equity of 29.93%. The firm's revenue for the quarter was up 3.8% on a year-over-year basis. During the same quarter in the prior year, the business earned $1.56 earnings per share. Solventum has set its FY 2025 guidance at 5.800-5.950 EPS. As a group, equities analysts predict that Solventum Corporation will post 6.58 EPS for the current fiscal year.

Solventum Profile

Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration.